Announcements Trials
Browse Landscape

Phase

Phase 1/2 2

Status

Completed 2

Sponsor Class

INDUSTRY 2

Study Type

Interventional 2

Sponsor

Cancer Type

Classical hematology 2Thoracic 1Sarcoma 1Lymphoid 1Head & Neck 1Gastrointestinal 1

Conditions

Fanconi Anemia 2Squamous Cell Carcinoma of Head and Neck 1Small Cell Lung Carcinoma 1Sarcoma 1Lymphoma, Non-Hodgkin 1Colorectal Neoplasms 1Anus Neoplasms 1

Interventions

fludarabine phosphate 4Antilymphocyte Serum 3fludarabine 2SRA737 2Peripheral Blood Stem Cell Transplantation 2Melphalan 2Cyclophosphamide 2Cord Blood Stem Cell Transplantation 2thymoglobulin 1sargramostim 1prexasertib 1Whole-Body Irradiation 1Thiotepa 1Tacrolimus 1Stem Cell Transplantation 1Reverse Transcriptase Polymerase Chain Reaction 1Radiotherapy 1Quercetin 1Polymerase Chain Reaction 1Mycophenolic Acid 1Microarray Analysis 1Methylprednisolone 1Immunoenzyme Techniques 1Gemcitabine 1Electrophoresis, Polyacrylamide Gel 1Dietary Supplements 1Clofarabine 1Cisplatin 1Chromatography, High Pressure Liquid 1Chromatography 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Fanconi Anemia × SRA737 × Clear all
NCT02797977 2023-06-22

A Phase 1/2 Trial SRA737 in Combination With Gemcitabine and Cisplatin or Gemcitabine Alone in Advanced Cancer Subjects

Sierra Oncology LLC - a GSK company

Phase 1/2 Completed
153 enrolled
Classical hematologySarcomaThoracic

Fanconi Anemia, Sarcoma, Small Cell Lung Carcinoma

NCT02797964 2023-06-18

A Phase 1/2 Trial of SRA737 in Subjects With Advanced Cancer

Sierra Oncology LLC - a GSK company

Phase 1/2 Completed
107 enrolled 20 charts
Classical hematologyGastrointestinalHead & NeckLymphoid

Squamous Cell Carcinoma of Head and Neck, Anus Neoplasms, Fanconi Anemia, Lymphoma, Non-Hodgkin, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡